NASDAQ

argenx awarded €2.5 million VLAIO grant to identify novel therapeutic antibodies

Grant to fund research of novel targets involved in regulation of locally-released TGF-beta, a ...

argenx awarded €2.5 million VLAIO grant to identify novel therapeutic antibodies

Grant to fund research of novel targets involved in regulation of locally-released TGF-beta, a ...

Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery

MINNEAPOLIS, March 15, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery

MINNEAPOLIS, March 15, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...